Triple T, a new minimally invasive therapy, could replace adrenal surgery for treating primary aldosteronism, a hidden cause ...

Medtech companies have their eye on the growing hospital-at-home market, which is driven largely by the rising elderly ...

During each session, participants wore Movano Health's wrist-worn device along with a hospital-grade FDA-cleared vital signs monitor with cuffed blood pressure measurements or utilizing arterial ...

Movano Health (Nasdaq:MOVE) announced today that it commenced a blood pressure clinical trial with its new cuffless wrist wearable.

Blood pressure is often measured alongside the vital signs (temperature, pulse rate, respiration rate) and is used to detect or monitor medical issues. Readings contain two numbers: systolic pressure ...

The study, which is expected to include at least 70 participants and be completed during the second week of February, utilizes the updated device to monitor pulse pressure waveforms in comparison with ...

Movano (MOVE) has commenced a blood pressure clinical trial with its newly developed cuffless blood pressure wrist wearable. The study, which ...

"I'm excited about the potential the enhanced design offers relative to our previous prototype as it represents a significant leap forward in cuffless blood pressure monitoring." Founded in 2018 ...

utilizes the updated device to monitor pulse pressure waveforms in comparison with a hospital grade blood pressure device. The new wearable will also collect data on a host of other vital signs ...

Blood test may detect stroke type before hospital arrival, allowing faster treatment American Stroke Association International Stroke Conference 2025 -- Abstract 47 Date: January 30, 2025 Source ...

Hospital chief medical officer R. Maruthavanan, former MLA P. Kalyanam were among those present. The van is fitted with blood donation couches, advanced blood collection monitoring and storing ...